NO149962C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivaterInfo
- Publication number
- NO149962C NO149962C NO783155A NO783155A NO149962C NO 149962 C NO149962 C NO 149962C NO 783155 A NO783155 A NO 783155A NO 783155 A NO783155 A NO 783155A NO 149962 C NO149962 C NO 149962C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- analogy procedure
- imidazold
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU78140 | 1977-09-19 | ||
| CH814978 | 1978-07-28 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO783155L NO783155L (no) | 1979-03-20 |
| NO149962B NO149962B (no) | 1984-04-16 |
| NO149962C true NO149962C (no) | 1984-07-25 |
Family
ID=25702876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO783155A NO149962C (no) | 1977-09-19 | 1978-09-18 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater |
Country Status (36)
| Country | Link |
|---|---|
| US (2) | US4182766A (no) |
| EP (1) | EP0001279B1 (no) |
| JP (1) | JPS5459274A (no) |
| AR (1) | AR224350A1 (no) |
| AT (1) | AT368152B (no) |
| AU (1) | AU519711B2 (no) |
| BG (1) | BG28708A3 (no) |
| BR (1) | BR7806148A (no) |
| CA (1) | CA1106849A (no) |
| DD (1) | DD138210A5 (no) |
| DE (2) | DE2861237D1 (no) |
| DK (1) | DK406578A (no) |
| EG (1) | EG13530A (no) |
| ES (1) | ES473451A1 (no) |
| FI (1) | FI64365C (no) |
| FR (1) | FR2403340A1 (no) |
| GB (1) | GB2004281B (no) |
| GR (1) | GR73069B (no) |
| HU (1) | HU176111B (no) |
| IE (1) | IE47363B1 (no) |
| IL (1) | IL55557A (no) |
| IN (1) | IN148930B (no) |
| IT (1) | IT1098858B (no) |
| MC (1) | MC1213A1 (no) |
| MT (1) | MTP835B (no) |
| NL (1) | NL7809529A (no) |
| NO (1) | NO149962C (no) |
| NZ (1) | NZ188405A (no) |
| OA (1) | OA06054A (no) |
| PH (1) | PH16342A (no) |
| PL (1) | PL114494B1 (no) |
| PT (1) | PT68573A (no) |
| RO (1) | RO75258A (no) |
| SE (1) | SE7809792L (no) |
| SU (1) | SU793390A3 (no) |
| YU (1) | YU216778A (no) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| US4321372A (en) * | 1980-06-16 | 1982-03-23 | Pfizer Inc. | Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides |
| US4359465A (en) * | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
| CH644116A5 (de) * | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | Imidazolderivate. |
| US4368201A (en) * | 1981-07-20 | 1983-01-11 | Usv Pharmaceutical Corporation | Tetrahydronaphthoxazoles |
| ZA825106B (en) * | 1981-08-13 | 1983-04-27 | Haessle Ab | Novel pharmaceutical compositions |
| IL71665A (en) * | 1983-05-03 | 1988-05-31 | Byk Gulden Lomberg Chem Fab | Fluoro-(2-pyridyl-methylthio)-dioxolo-(and dioxino-)benzimidazoles,processes for their preparation and pharmaceutical compositions containing the same |
| ZW4585A1 (en) * | 1984-04-19 | 1985-11-20 | Hoffmann La Roche | Imidazole derivatives |
| CA1341314C (en) * | 1984-07-06 | 2001-11-06 | David Cox | Derivatives of benzimidazole, benzothiazole and benzoxazole |
| GB2161160B (en) * | 1984-07-06 | 1989-05-24 | Fisons Plc | Heterocyclic sulphinyl compounds |
| SE8404065D0 (sv) * | 1984-08-10 | 1984-08-10 | Haessle Ab | Novel biologically active compounds |
| DE3501497A1 (de) * | 1985-01-18 | 1986-07-24 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
| US5869513A (en) * | 1985-05-24 | 1999-02-09 | G. D. Searle & Co. | 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines |
| EP0204215B1 (en) | 1985-05-24 | 1993-08-11 | G.D. Searle & Co. | 2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-benzenamines |
| DK337086A (da) * | 1985-08-12 | 1987-02-13 | Hoffmann La Roche | Benzimidazolderivater |
| SE8505112D0 (sv) * | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
| SE8600658D0 (sv) * | 1986-02-14 | 1986-02-14 | Haessle Ab | Novel composition of matter |
| US4687775A (en) * | 1986-07-17 | 1987-08-18 | G. D. Searle & Co. | 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles |
| US4772619A (en) * | 1986-07-17 | 1988-09-20 | G. D. Searle & Co. | [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines |
| US4721718A (en) * | 1986-08-18 | 1988-01-26 | G. D. Searle & Co. | 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers |
| SE8604566D0 (sv) * | 1986-10-27 | 1986-10-27 | Haessle Ab | Novel compunds |
| NZ234564A (en) | 1986-11-21 | 1991-04-26 | Haessle Ab | 1-substituted benzimidazoles and pharmaceutical compositions |
| SE8604998D0 (sv) | 1986-11-21 | 1986-11-21 | Haessle Ab | Novel pharmacological compounds |
| FI91754C (fi) * | 1986-12-02 | 1994-08-10 | Tanabe Seiyaku Co | Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi |
| DE3701277A1 (de) * | 1987-01-17 | 1988-07-28 | Boehringer Mannheim Gmbh | Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel |
| US4931557A (en) * | 1988-10-17 | 1990-06-05 | Eli Lilly And Company | Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof |
| SE8804629D0 (sv) | 1988-12-22 | 1988-12-22 | Ab Haessle | New therapeutically active compounds |
| SE8804628D0 (sv) | 1988-12-22 | 1988-12-22 | Ab Haessle | New compounds |
| IE64199B1 (en) * | 1988-12-22 | 1995-07-12 | Haessle Ab | Compound with gastric acid inhibitory effect and process for its preparation |
| US4965269A (en) * | 1989-12-20 | 1990-10-23 | Ab Hassle | Therapeutically active chloro substituted benzimidazoles |
| US5274099A (en) * | 1989-12-20 | 1993-12-28 | Aktiebolaget Hassle | Therapeutically active fluoro substituted benzimidazoles |
| US5049674A (en) * | 1989-12-20 | 1991-09-17 | Aktiebolaget Hassle | Therapeutically active fluoro substituted benzimidazoles |
| SE9002043D0 (sv) * | 1990-06-07 | 1990-06-07 | Astra Ab | Improved method for synthesis |
| SE9002206D0 (sv) | 1990-06-20 | 1990-06-20 | Haessle Ab | New compounds |
| PL307026A1 (en) * | 1992-07-08 | 1995-05-02 | Monsanto Co | Method of producing ppaliative effect in respect to swine gastric ulcers |
| AU2395095A (en) | 1994-04-29 | 1995-11-29 | G.D. Searle & Co. | Method of using (h+/k+) atpase inhibitors as antiviral agents |
| HU227566B1 (en) * | 1995-09-21 | 2011-08-29 | Pharma Pass Llc | Acid-labile pharmaceutical composition containing omeprazole and process for its preparation |
| US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US5840737A (en) * | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| KR100463031B1 (ko) * | 1997-05-26 | 2005-04-06 | 동아제약주식회사 | 5-메톡시-2-[3,5-디메틸-4-메톡시피리딜메틸)설피닐]-1h-벤즈이미다졸의신규제조방법 |
| US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
| US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
| US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
| US20040006111A1 (en) * | 2002-01-25 | 2004-01-08 | Kenneth Widder | Transmucosal delivery of proton pump inhibitors |
| US20040248942A1 (en) * | 2003-02-20 | 2004-12-09 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| MXPA06000529A (es) * | 2003-07-18 | 2006-08-11 | Santarus Inc | Formulaciones farmaceuticas utiles para inhibir la secrecion de acido y metodos para elaborarlas y utilizarlas. |
| US8993599B2 (en) * | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| CA2531566C (en) * | 2003-07-18 | 2013-05-07 | Santarus, Inc. | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
| US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
| US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US20060024362A1 (en) | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
| CA2665226C (en) | 2006-10-05 | 2014-05-13 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
| US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
| MX2009004475A (es) | 2006-10-27 | 2009-08-12 | Univ Missouri | Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma. |
| WO2024075017A1 (en) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition of aortic valve calcification |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2985661A (en) * | 1956-02-06 | 1961-05-23 | American Cyanamid Co | Preparation of 2(omicron-aminophenyl)-benzimidazole |
| GB1234058A (no) * | 1968-10-21 | 1971-06-03 | ||
| SE418966B (sv) * | 1974-02-18 | 1981-07-06 | Haessle Ab | Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan |
| SE416649B (sv) * | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
-
1978
- 1978-08-30 IN IN949/CAL/78A patent/IN148930B/en unknown
- 1978-08-31 MC MC781323A patent/MC1213A1/xx unknown
- 1978-09-11 US US05/941,343 patent/US4182766A/en not_active Expired - Lifetime
- 1978-09-12 IL IL55557A patent/IL55557A/xx unknown
- 1978-09-13 AU AU39817/78A patent/AU519711B2/en not_active Expired
- 1978-09-13 EG EG554/78A patent/EG13530A/xx active
- 1978-09-13 BG BG7840865A patent/BG28708A3/xx unknown
- 1978-09-13 NZ NZ188405A patent/NZ188405A/xx unknown
- 1978-09-13 CA CA311,181A patent/CA1106849A/en not_active Expired
- 1978-09-14 DK DK406578A patent/DK406578A/da not_active Application Discontinuation
- 1978-09-14 OA OA56607A patent/OA06054A/xx unknown
- 1978-09-14 YU YU02167/78A patent/YU216778A/xx unknown
- 1978-09-14 PH PH21603A patent/PH16342A/en unknown
- 1978-09-14 FR FR7826420A patent/FR2403340A1/fr active Granted
- 1978-09-15 DD DD78207858A patent/DD138210A5/xx unknown
- 1978-09-18 SU SU782664651A patent/SU793390A3/ru active
- 1978-09-18 EP EP78100923A patent/EP0001279B1/de not_active Expired
- 1978-09-18 FI FI782847A patent/FI64365C/fi not_active IP Right Cessation
- 1978-09-18 GR GR57249A patent/GR73069B/el unknown
- 1978-09-18 MT MT835A patent/MTP835B/xx unknown
- 1978-09-18 JP JP11371578A patent/JPS5459274A/ja active Pending
- 1978-09-18 PT PT68573A patent/PT68573A/pt unknown
- 1978-09-18 DE DE7878100923T patent/DE2861237D1/de not_active Expired
- 1978-09-18 GB GB7837156A patent/GB2004281B/en not_active Expired
- 1978-09-18 AT AT0673378A patent/AT368152B/de not_active IP Right Cessation
- 1978-09-18 SE SE7809792A patent/SE7809792L/xx unknown
- 1978-09-18 NO NO783155A patent/NO149962C/no unknown
- 1978-09-18 DE DE19782840591 patent/DE2840591A1/de not_active Withdrawn
- 1978-09-18 IE IE1878/78A patent/IE47363B1/en unknown
- 1978-09-18 HU HU78HO2102A patent/HU176111B/hu unknown
- 1978-09-18 ES ES473451A patent/ES473451A1/es not_active Expired
- 1978-09-19 BR BR7806148A patent/BR7806148A/pt unknown
- 1978-09-19 PL PL1978209693A patent/PL114494B1/pl unknown
- 1978-09-19 RO RO7895228A patent/RO75258A/ro unknown
- 1978-09-19 AR AR273765A patent/AR224350A1/es active
- 1978-09-19 IT IT27861/78A patent/IT1098858B/it active
- 1978-09-19 NL NL7809529A patent/NL7809529A/xx not_active Application Discontinuation
-
1979
- 1979-07-02 US US06/054,210 patent/US4248880A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO149962C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater | |
| NO147148C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater | |
| NO150800C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tricykliske forbindelser | |
| NO151321C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater | |
| NO151463C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater | |
| NO148148C (no) | Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater | |
| NO800858L (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater | |
| NO156611C (no) | Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre. | |
| NO151240C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive nitroimidazoler | |
| NO148813C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater | |
| NO800881L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater | |
| NO148777C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater | |
| NO149065C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater | |
| NO146359C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater | |
| NO149313C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
| NO149737C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer | |
| NO149037C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
| NO148454C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater | |
| NO148451C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive oximethere | |
| NO150158C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater | |
| NO146057C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoalkoholderivater | |
| NO149960C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive bis(nitrosoureido)-polyolderivater | |
| NO794318L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater | |
| NO780644L (no) | Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater | |
| NO149964C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-(tetrazol-5-yl)-1-azaxanthoner |